Rescheduling Should Send MJ And MSOS Sky High
2025-08-13 12:08:23 ET
American cannabis stocks have surged over the past few days following President Donald Trump’s announcement that he is considering reclassifying marijuana . Currently, marijuana is classified as a Schedule I drug , along with LSD and ecstasy. Go figure, fentanyl is “only” considered a Schedule II drug even though it kills far more people. The Biden administration had considered scheduling marijuana as a Schedule III drug, alongside testosterone and Tylenol with codeine, but ultimately, efforts didn’t advance. Now, it looks like the Trump administration may press ahead and reschedule marijuana as a Schedule III drug. The mere possibility of rescheduling has sent cannabis stocks and ETFs rocking upward, as illustrated below....
Read the full article on Seeking Alpha
For further details see:
Rescheduling Should Send MJ And MSOS Sky High
NASDAQ: MSOS
MSOS Trading
11.64% G/L:
$5.59 Last:
11,139,831 Volume:
$5.35 Open:
